JD Health International Inc. JD Health International Inc.

JD Health International Inc.

6618

주식 순위 #1385
JD Health International Inc., functioning as an investment holding entity, runs... JD Health International Inc., functioning as an investment holding entity, runs an expansive digital healthcare platform across the People's Republic of China. The company supplies a diverse range of pharmaceutical and wellness products, such as over-the-counter and prescription medications, medical devices, and health supplements. These goods are distributed through both direct sales and an extensive online retail pharmacy network. Beyond product offerings, its comprehensive service suite includes virtual medical consultations, patient referrals to hospitals and doctors, health screening programs, genetic testing, and beauty care services. Additionally, it develops intelligent healthcare and wellness management solutions, alongside providing technical support and advertising services. The platform also facilitates access to various medical provisions, including general health examinations, cosmetic medical procedures, vaccination bookings, dental treatments, and nucleic acid testing. Incorporated in 2018 and headquartered in Beijing, People's Republic of China, JD Health International Inc. is a subsidiary of JD Jiankang Limited.
주가
$5.06
시가총액
$16.15B
변동 (1일)
2.59%
변동 (1년)
-37.75%
국가
CN
거래 JD Health International Inc. (6618)

카테고리

Healthcare
JD Health International Inc. (6618)의 EPS
June 2026 기준 EPS TTM: $0.28
JD Health International Inc.의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $0.28입니다. 2023년 말에는 회사의 EPS가 $0.10였으며, 이는 2022년의 EPS $0.02와 증가입니다.
JD Health International Inc.의 EPS 기록 (2017 ~ 2026)
매년 말의 EPS
연도 EPS 변화
2026 (TTM) $0.28 54.56%
2024 $0.18 88.14%
2023 $0.10 452.30%
2022 $0.02 -131.58%
2021 $-0.06 -95.39%
2020 $-1.19 1,748.30%
2019 $-0.06 -746.00%
2018 $0.01 13.64%
2017 $0.01 0.00%
유사 기업 또는 경쟁사의 EPS